G. Pelaia, R. Maselli, and L. Gallelli, “Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium”, Multidiscip Respir Med, vol. 9, no. 1, Dec. 2014, doi: 10.4081/mrm.2014.399.